 | | Vol. 13.42 – 25 November, 2021 |
| |
|
|
| Scientists investigated the impact of cord blood transplantation, and compared to human leukocyte antigen-matched related donor transplantation.
[Leukemia] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers evaluated individual and joint associations of prenatal metals with mitochondrial DNA copy number and telomere length in maternal and cord blood as biomarkers of inflammation and oxidative stress.
[Environmental Health Perspectives] |
|
|
|
| Scientists investigated the function of long non-coding RNA MEG3 and its derived miR-770 in perfluorooctane sulfonic acid (PFOS)-induced placental toxicity.
[Environmental Pollution] |
|
|
|
| Researchers analyzed the extent to which metals measured in maternal erythrocytes were associated with differentially methylated positions and regions in cord blood and tested if associations persisted in blood collected in mid-childhood.
[Clinical Epigenetics] |
|
|
|
| An optimized combination of enzymatic solutions with mechanical scrapping was used to remove the amniotic epithelium and chorion trophoblastic layer of a placenta membrane, which resulted in exposing the basement membranes of both sides without their separation and subsequent damages to the in-between spongy layer.
[Scientific Reports] |
|
|
|
| Researchers combined determination of bile acids and molecular lipids by liquid chromatography with ultra-high-resolution mass spectrometry, and separately quantified cord blood concentrations of sixteen poly-/per-fluoroalkyl substances in a cohort of Chinese infants.
[Metabolomics] |
|  |
|
|
|
| The authors conclude that many similarities between trophoblast and cancer cells are shared with other, phylogenetically older processes than placentation.
[Annual Review of Animal Biosciences] |
|
|
|
|
| Affimed N.V. announced interim clinical results from the investigator-initiated Phase I-II study at The University of Texas MD Anderson Cancer Center, evaluating cbNK cells pre-complexed with Affimed’s innate cell engager AFM13.
[Affimed N.V.] |
|
|
|
|
| January 23 – 26, 2022
Santa Fe, New Mexico, United States |
|
|
|
|
|
| | Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| | Karolinska Institutet – Flemingsberg, Sweden |
|
|
|
| | University Children’s Hospital Zurich – Zurich, Switzerland |
|
|
|
| | Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
| | Duke University – Durham, North Carolina, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
